Literature DB >> 22647247

A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults.

Linn A Vikøren1, Ottar K Nygård1, Einar Lied1, Espen Rostrup1, Oddrun A Gudbrandsen1.   

Abstract

The popularity of high-protein diets for weight reduction is immense. However, the potential benefits from altering the source of dietary protein rather than the amount is scarcely investigated. In the present study, we examined the effects of fish protein supplement on glucose and lipid metabolism in overweight adults. A total of thirty-four overweight adults were randomised to 8 weeks' supplementation with fish protein or placebo tablets (controls). The intake of fish protein supplement was 3 g/d for the first 4 weeks and 6 g/d for the last 4 weeks. In this study, 8 weeks of fish protein supplementation resulted in lower values of fasting glucose (P< 0·05), 2 h postprandial glucose (P< 0·05) and glucose-area under the curve (AUC) (five measurements over 2 h, P< 0·05) after fish protein supplementation compared to controls. Glucose-AUC was decreased after 8 weeks with fish protein supplement compared to baseline (P< 0·05), concomitant with increased 30 min and decreased 90 min and 2 h insulin C-peptide level (P< 0·05), and reduced LDL-cholesterol (P< 0·05). Body muscle % was increased (P< 0·05) and body fat % was reduced (P< 0·05) after 4 weeks' supplementation. Physical activity and energy and macronutrients intake did not change during the course of the study. In conclusion, short-term daily supplementation with a low dose of fish protein may have beneficial effects on blood levels of glucose and LDL-cholesterol as well as glucose tolerance and body composition in overweight adults. The long-term effects of fish protein supplementation is of interest in the context of using more fish as a protein source in the diet, and the effects of inclusion of fish in the diet of individuals with low glucose tolerance should be evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647247     DOI: 10.1017/S0007114512001717

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  28 in total

1.  A low dietary intake of cod protein is sufficient to increase growth, improve serum and tissue fatty acid compositions, and lower serum postprandial glucose and fasting non-esterified fatty acid concentrations in obese Zucker fa/fa rats.

Authors:  Aslaug Drotningsvik; Svein Are Mjøs; Ingmar Høgøy; Tore Remman; Oddrun Anita Gudbrandsen
Journal:  Eur J Nutr       Date:  2014-11-08       Impact factor: 5.614

2.  Consumption of salmon fishmeal increases hepatic cholesterol content in obese C57BL/6 J mice.

Authors:  Marit Hjorth; Atanaska Doncheva; Frode Norheim; Stine Marie Ulven; Kirsten Bjørklund Holven; Thomas Sæther; Knut Tomas Dalen
Journal:  Eur J Nutr       Date:  2022-07-05       Impact factor: 5.614

3.  Effects of low doses of fish and milk proteins on glucose regulation and markers of insulin sensitivity in overweight adults: a randomised, double blind study.

Authors:  Ida Heir Hovland; Ingrid Sande Leikanger; Oddbjørg Stokkeland; Kaia Hevrøy Waage; Svein A Mjøs; Karl A Brokstad; Adrian McCann; Per Magne Ueland; Rasa Slizyte; Ana Carvajal; Gunnar Mellgren; Tore Remman; Ingmar Høgøy; Oddrun A Gudbrandsen
Journal:  Eur J Nutr       Date:  2019-04-10       Impact factor: 5.614

4.  Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.

Authors:  Marion Valle; Patricia L Mitchell; Geneviève Pilon; Philippe St-Pierre; Thibault Varin; Denis Richard; Marie-Claude Vohl; Hélène Jacques; Edgar Delvin; Emile Levy; Claudia Gagnon; Laurent Bazinet; André Marette
Journal:  J Nutr       Date:  2021-05-11       Impact factor: 4.798

5.  Scallop protein with endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid profile in male C57BL/6J mice.

Authors:  Hanne Sørup Tastesen; Alison H Keenan; Lise Madsen; Karsten Kristiansen; Bjørn Liaset
Journal:  Amino Acids       Date:  2014-07       Impact factor: 3.520

Review 6.  Preclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides-A Review.

Authors:  Ida-Johanne Jensen; Hanne K Mæhre
Journal:  Mar Drugs       Date:  2016-11-18       Impact factor: 5.118

7.  Associations between fish intake and the metabolic syndrome and its components among middle-aged men and women: the Hordaland Health Study.

Authors:  Therese Karlsson; Hanne Rosendahl-Riise; Jutta Dierkes; Christian A Drevon; Grethe S Tell; Ottar Nygård
Journal:  Food Nutr Res       Date:  2017-07-13       Impact factor: 3.894

8.  Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile acids in overweight adults: a randomised clinical trial.

Authors:  Marianne Bratlie; Ingrid V Hagen; Anita Helland; Friedemann Erchinger; Øivind Midttun; Per Magne Ueland; Grethe Rosenlund; Harald Sveier; Gunnar Mellgren; Trygve Hausken; Oddrun Anita Gudbrandsen
Journal:  Eur J Nutr       Date:  2020-10-27       Impact factor: 5.614

9.  Using Blood Indexes to Predict Overweight Statuses: An Extreme Learning Machine-Based Approach.

Authors:  Huiling Chen; Bo Yang; Dayou Liu; Wenbin Liu; Yanlong Liu; Xiuhua Zhang; Lufeng Hu
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 10.  Nutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk Reduction.

Authors:  Giulia Chiesa; Marco Busnelli; Stefano Manzini; Cinzia Parolini
Journal:  Mar Drugs       Date:  2016-06-08       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.